{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:38Z","timestamp":1786984298856,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["NCT00069784"],"award-info":[{"award-number":["NCT00069784"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.amjmed.2017.05.047","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T18:00:32Z","timestamp":1504202432000},"page":"1465.e27-1465.e39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study"],"prefix":"10.1016","volume":"130","author":[{"given":"Vasilios","family":"Papademetriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Nylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Probstfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes F.E.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel C.","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2017.05.047_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0015","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0020","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0025","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0030","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI clinical practice guidelines for diabetes and CKD: 2012 update","volume":"60","author":"National Kidney Foundation","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2014.296","article-title":"Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes","volume":"87","author":"Papademetriou","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0050","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independantly predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0055","first-page":"26","article-title":"Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)","volume":"155","author":"Gerstein","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"The ORIGIN Trial Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia","volume":"367","author":"Bosch","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0070","first-page":"S1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10157-011-0420-6","article-title":"Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia","volume":"15","author":"Tanaka","year":"2001","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0080","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00125-014-3238-4","article-title":"Basal insulin glargine and microvascular outcomes in dysglycemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial","volume":"57","author":"Gilbert","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13300-016-0153-3","article-title":"Early treatment with basal insulin glargine in people with type 2 diabetes: lessons from ORIGIN and other cardiovascular trials","volume":"7","author":"Hanefeld","year":"2016","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1464-5491.2009.02915.x","article-title":"Effect of targeting normal fasting glucose levels with basal insulin glargine on glycemic variability and risk of hypoglycemia: a randomized, controlled study in patients with early type 2 diabetes","volume":"27","author":"Hanefeld","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0095","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2337\/dc15-1676","article-title":"Cardiovascular and other outcomes post-intervention with insulin glargine and omega-3 fatty acids (ORIGINALE)","volume":"39","author":"ORIGIN Trial Investigators","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0100","doi-asserted-by":"crossref","first-page":"e0132047","DOI":"10.1371\/journal.pone.0132047","article-title":"Interrelationship of multiple endothelial dysfunction biomarkers with chronic kidney disease","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0110","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jacc.2008.09.055","article-title":"The continuum of diabetic vascular disease: from macro- to micro","volume":"53","author":"Orasanu","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0115","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/ndt\/gfv467","article-title":"Urinary biomarkers to predict CKD: is the future in multi-marker panels?","volume":"31","author":"Pontillo","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/0886022X.2014.982489","article-title":"Early markers of cardiovascular risk in chronic kidney disease","volume":"37","author":"Lai","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.amjmed.2017.05.047_bib0125","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/eurheartj\/eht332","article-title":"Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial","volume":"34","author":"Mellbin","year":"2013","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934317307052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934317307052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:12:57Z","timestamp":1757581977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934317307052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0002934317307052"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.05.047","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2017.05.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}